Package 76420-015-90

{"route": ["ORAL"], "spl_id": "ead11d10-7482-8d9b-e053-2a95a90a2c68", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431"], "spl_set_id": ["e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "240 CAPSULE in 1 BOTTLE (76420-015-24)", "package_ndc": "76420-015-24", "marketing_start_date": "20200123"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-015-30)", "package_ndc": "76420-015-30", "marketing_start_date": "20200123"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-015-60)", "package_ndc": "76420-015-60", "marketing_start_date": "20200123"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-015-90)", "package_ndc": "76420-015-90", "marketing_start_date": "20200123"}], "brand_name": "Gabapentin", "product_id": "76420-015_ead11d10-7482-8d9b-e053-2a95a90a2c68", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-015", "generic_name": "Gabapentin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA075350", "marketing_category": "ANDA", "marketing_start_date": "20140403", "listing_expiration_date": "20261231"}